Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.Unknown journal · 2026-06-30Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.Unknown journal · 2026-06-30Psychedelics as a potential treatment for borderline personality disorder: A narrative review.Psychiatry research · 2026-06-30Human brain changes after first psilocybin use.Unknown journal · 2026-05-04Effects of psychedelic use on authoritarian attitudes revisitedJournal of Psychopharmacology · 2026-04-30Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal CortexhBiological Psychiatry · 2026-04-24An international mega-analysis of psychedelic drug effects on brain circuit functionNature Medicine · 2026-03-31The combination of exercise and psychedelics for the treatment of major depressive disorder.Discover mental health · 2026-03-06Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical TrialsACS Pharmacology & Translational Science · 2026-03-02Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-02-11Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-01-18Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxietyGeneral Hospital Psychiatry · 2025-12-08Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-11-21A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying LensPsychoactives · 2025-11-13Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.Unknown journal · 2025-11-06A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?ClinicalTrials.gov · 2025-10-28Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trialPilot and Feasibility Studies · 2025-10-27Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.Unknown journal · 2025-10-15Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.Unknown journal · 2025-09-14Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Unknown journal · 2025-09-06Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreatFrontiers in Psychiatry · 2025-08-05Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Unknown journal · 2025-07-17Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed NeuroimagingbioRxiv · 2025-07-02Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic ExperienceBrain and Behavior · 2025-06-30Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.Unknown journal · 2025-06-30Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat SettingsBrain and Behavior · 2025-06-30Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionJournal of Psychopharmacology · 2025-06-30Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studiesFrontiers in Psychology · 2025-06-05Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey StudyJournal of Addiction Medicine · 2025-05-27Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Unknown journal · 2025-05-07Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesMolecular Psychiatry · 2025-04-25194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-08187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-08186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-0858. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-08323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study ParticipationBiological Psychiatry · 2025-04-08Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trialNeuropsychopharmacology · 2025-04-08Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavementBMJ Open · 2025-03-31Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étudeThe Canadian Journal of Psychiatry · 2025-03-24Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with DepressionbioRxiv · 2025-03-09Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexitybioRxiv · 2024-12-21Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II DisorderPsychedelic Medicine · 2024-11-17Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-06Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional propertiesNature Mental Health · 2024-10-13Human brain changes after first psilocybin usebioRxiv · 2024-10-13Memory, trauma, and self: Remembering and recovering from sexual abuse in psychedelic-assisted therapyJournal of Psychedelic Studies · 2024-10-08Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.Unknown journal · 2024-10-02A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-18Psychedelic-assisted psychotherapy: where is the psychotherapy research?Psychopharmacology · 2024-07-31Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depressionTrials · 2024-07-02Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experiencebioRxiv · 2024-06-12Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.Unknown journal · 2024-05-30Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.Unknown journal · 2024-03-31Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-06Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13Psychedelics and sexual functioning: a mixed-methods studyScientific Reports · 2024-02-06Letter to the Editor: Will Psilocybin-Assisted Therapy Reduce the Incidence of Medical Assistance in Dying?Unknown journal · 2024-01-31A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Unknown journal · 2024-01-17Psychedelics: The New Kid on the BlockAnnals of Indian Psychiatry · 2023-12-31Is Poorly Assisted Psilocybin Treatment an Increasing Risk?Unknown journal · 2023-12-31Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.Unknown journal · 2023-10-10Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Unknown journal · 2023-08-23A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolUnknown journal · 2023-07-18Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depressionmedRxiv · 2023-06-02Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experiencebioRxiv · 2023-05-11High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybinbioRxiv · 2023-04-13Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.Unknown journal · 2023-03-21Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put FirstPsychiatric News · 2023-02-15The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.Journal of psychoactive drugs · 2022-12-31Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.Frontiers in psychiatry · 2022-12-31Canalization and plasticity in psychopathology.Unknown journal · 2022-12-26Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.Journal of Psychopharmacology · 2022-11-25Body mass index (BMI) does not predict responses to psilocybin.Journal of Psychopharmacology · 2022-11-13Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.Contemporary Clinical Trials · 2022-11-01A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive EmergencyJournal of the American Society of Nephrology · 2022-10-31Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.Nature Communications · 2022-10-02A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Unknown journal · 2022-10-02Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.Unknown journal · 2022-09-30Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.Network Neuroscience · 2022-09-30Brain dynamics predictive of response to psilocybin for treatment-resistant depressionResearch Square · 2022-09-19Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.Unknown journal · 2022-09-11Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych Open · 2022-09-05The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Unknown journal · 2022-08-16The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-08-07Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter LandscapebioRxiv · 2022-07-12Brain dynamics predictive of response to psilocybin for treatment-resistant depressionbioRxiv · 2022-07-03The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.Unknown journal · 2022-04-25Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.NeuroImage · 2022-04-24Increased global integration in the brain after psilocybin therapy for depression.Nature Medicine · 2022-04-10Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?Psychiatric News · 2022-03-23Increased low-frequency brain responses to music after psilocybin therapy for depressionbioRxiv · 2022-02-14Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.Current topics in behavioral neurosciences · 2021-12-31Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.Frontiers in pharmacology · 2021-12-31Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?Frontiers in psychiatry · 2021-12-31P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to musicEuropean Neuropsychopharmacology · 2021-11-30Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.Unknown journal · 2021-11-16Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational Psychiatry · 2021-11-07Decreased brain modularity after psilocybin therapy for depression.Research Square · 2021-05-19Registered clinical studies investigating psychedelic drugs for psychiatric disorders.Unknown journal · 2021-05-17LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theorybioRxiv · 2021-05-16The emerging role of psilocybin and MDMA in the treatment of mental illness.Unknown journal · 2020-09-29Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortexbioRxiv · 2020-05-02Microdosing psychedelics: Demographics, practices, and psychiatric comorbiditiesJournal of Psychopharmacology · 2020-02-27Scalable Hybrid Synthetic/Biocatalytic Route to PsilocybinChemistry - A European Journal · 2020-02-25Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depressionJournal of Psychopharmacology · 2020-01-15P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depressionEuropean Neuropsychopharmacology · 2019-11-30Psychedelic microdosing benefits and challenges: an empirical codebookHarm Reduction Journal · 2019-07-08Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybinNeuroImage · 2019-05-23Serotonergic Psychedelics LSD & Psilocybin Increase the Fractal Dimension of Cortical Brain Activity in Spatial and Temporal DomainsbioRxiv · 2019-01-10Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review.Unknown journal · 2019-01-02Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.Unknown journal · 2019-01-01Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosersPsyArXiv · 2018-11-01Psychedelics, Meditation, and Self-Consciousness.Frontiers in Psychology · 2018-09-03Altered trajectories in the dynamical repertoire of functional network states under psilocybinbioRxiv · 2018-07-24Effects of psilocybin therapy on personality structure.Acta Psychiatrica Scandinavica · 2018-06-18The hidden therapist: evidence for a central role of music in psychedelic therapy.Psychopharmacology · 2018-02-01Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.Frontiers in Pharmacology · 2018-01-16Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.Neuropharmacology · 2017-12-26Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific Reports · 2017-10-12Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.Human Brain Mapping · 2015-05-21The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.Frontiers in Human Neuroscience · 2014-05-26Current Research on the Human Experience of Spirituality Following the Ingestion of ‘Magic’ Psilocybin Mushrooms: An Annotated Bibliography for Social Workers and Other Health Care ProfessionalsSSRN Electronic Journal · 2009-12-31A characteristic effect of hallucinogens on investigatory responding in rats.Unknown journal · 1979-08-31The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.Unknown journal · 1978-11-30Comparison of three psychotropic drugs (psilocybin, JB-329, and IT-290) in volunteer subjects.Unknown journal · 1960-10-31